Published in Biotech Business Week, May 19th, 2003
The success of the Prevnar vaccine, produced by Wyeth after the company licensed basic technology from the university, is covered in the May 1, 2003, issue of the New England Journal of Medicine. The numbers translate to roughly 20,000 fewer cases of infection each year in the United States, with the greatest prevention among the youngest children.
Prevnar was introduced in 2000 to prevent invasive...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.